Latest Market Research Reports

Europe Pharmaceutical Industry Overview The  Europe pharmaceutical market  size is expected to reach USD 432.12 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.4% from 2021 to 2028. The market is driven by an increasing prevalence of diseases, a growing elderly population, and the approval and launch of novel products in the European region. Europe Pharmaceutical Market Segmentation Grand View Research has segmented the Europe pharmaceutical market based on product, type, therapeutic category, and region: Based on the Product Insights, the market is segmented into Branded, Generic. The branded segment accounted for the largest revenue share of over 65.0% in 2020 owing to the presence of key drug manufacturers and clinical-based pharmaceutical companies in the region. Increasing R&D efforts, the growing adoption of novel therapies, and strategic collaborations are likely to boost the penetration of t...

Shingles Vaccine Industry Overview The global shingles vaccine market size was valued at 2.99 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 9.9% from 2021 to 2028. The increased risk of developing shingles, especially in adults aged 60 and above, and improvement in healthcare policies in developed countries are factors expected to fuel the market growth. According to the CDC estimates, around one out of three individuals in the U.S. will develop shingles in their lifetime. Vaccination is recommended in major countries such as the U.S. Canada, the U.K., Italy, Germany, Australia, New Zealand, and South Korea. In March 2021, the CDC released guidelines related to shingles vaccination during the COVID-19 pandemic and designated it as an essential preventive care service. The shift towards novel  recombinant vaccines,  coupled with their high prices, is anticipated to propel market growth over the forecast period. Moreover, the U.S. Adviso...